{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:44:15Z","timestamp":1789245855377,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2024425"],"award-info":[{"award-number":["2018R1A5A2024425"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C2006318"],"award-info":[{"award-number":["2022R1A2C2006318"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A6A1A03046247"],"award-info":[{"award-number":["2022R1A6A1A03046247"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014M3A9D5A01073556"],"award-info":[{"award-number":["NRF-2014M3A9D5A01073556"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lfs.2024.122443","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T09:27:49Z","timestamp":1705570069000},"page":"122443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["An ROR\u03b1 agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3"],"prefix":"10.1016","volume":"340","author":[{"given":"Haena","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Chambugong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ock","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeung-geun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122443_bb0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2024.122443_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.122443_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev-pharmtox-010617-052545","article-title":"Nonalcoholic steatohepatitis (NASH) and hepatic fibrosis: emerging therapies","volume":"58","author":"Wattacheril","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2024.122443_bb0020","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2024.122443_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122443_bb0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122443_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2024.122443_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2024.122443_bb0045","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.07003","article-title":"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism","volume":"7","author":"Jetten","year":"2009","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.lfs.2024.122443_bb0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.25529","article-title":"Retinoic acid receptor-related orphan receptor alpha-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis","volume":"55","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122443_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd4100","article-title":"REV-ERB and ROR nuclear receptors as drug targets","volume":"13","author":"Kojetin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2024.122443_bb0060","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI124219","article-title":"A maresin 1\/RORalpha\/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis","volume":"129","author":"Han","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.lfs.2024.122443_bb0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA attenuates nonalcoholic fatty liver progression in mice via up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122443_bb0070","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1089\/ars.2013.5655","article-title":"ROR alpha decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice","volume":"21","author":"Han","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2024.122443_bb0075","article-title":"Liver-specific deletion of RORalpha aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122443_bb0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41467-017-00215-1","article-title":"RORalpha controls hepatic lipid homeostasis via negative regulation of PPARgamma transcriptional network","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122443_bb0085","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12272-012-0809-0","article-title":"N-methylthioureas as new agonists of retinoic acid receptor-related orphan receptor","volume":"35","author":"Park","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2024.122443_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78077-9","article-title":"Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122443_bb0095","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.510230648","article-title":"Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration","volume":"23","author":"Vrochides","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122443_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/105221617X15093707969658","article-title":"Updates on dietary models of nonalcoholic fatty liver disease: current studies and insights","volume":"18","author":"Stephenson","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.lfs.2024.122443_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118007","article-title":"RORalpha autoregulates its transcription via MLL4-associated enhancer remodeling in the liver","volume":"256","author":"Han","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2024.122443_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nsmb925","article-title":"The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1","volume":"12","author":"Akashi","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.lfs.2024.122443_bb0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2017.06.017","article-title":"ROR alpha induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis","volume":"20","author":"Han","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2024.122443_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/cb100223d","article-title":"Identification of SR1078, a synthetic agonist for the orphan nuclear receptors ROR alpha and ROR gamma","volume":"5","author":"Wang","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.lfs.2024.122443_bb0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.109.060905","article-title":"The benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha\/gamma inverse agonist","volume":"77","author":"Kumar","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122443_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.122443_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","article-title":"3,5-Diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research","volume":"1981","author":"Pose","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2024.122443_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.gastro.2019.05.066","article-title":"Aryl hydrocarbon receptor signaling prevents activation of hepatic stellate cells and liver fibrogenesis in mice","volume":"157","author":"Yan","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122443_bb0145","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122443_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3350\/cmh.2020.0187","article-title":"Anti-fibrotic treatments for chronic liver diseases: the present and the future","volume":"27","author":"Odagiri","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2024.122443_bb0155","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122443_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122443_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","article-title":"SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122443_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/futurepharmacol3010017","article-title":"Obeticholic acid—a pharmacological and clinical review","volume":"3","author":"Keshvani","year":"2023","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.lfs.2024.122443_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-023-00796-x","article-title":"Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach","author":"Brennan","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T02:58:31Z","timestamp":1714100311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"alternative-id":["S0024320524000328"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122443","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ROR\u03b1 agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122443"}}